Literature DB >> 255553

An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiologic studies.

K Crossley, B Landesman, D Zaske.   

Abstract

Studies to determine the epidemiologic behavior of strains of Staphylococcus aureus resistant to methicillin and aminoglycosides (MARS) were conducted over a period of two and one-half years, during which MARS were isolated from 201 patients at a hospital in the midwestern United States. Most cases of infection or colonization with MARS (156 of 201) occurred in patients with burns. In the burn unit, MARS were recovered from the air, from the hair and hands of personnel, and from inanimate objects. Nasal (72%) and rectal (66%) colonization were common among burned patients with infected or colonized burn wounds but occurred in only six of 74 burn unit personnel. When compared with two control periods, the prophylactic use of antistaphylococcal agents in patients with burns increased markedly at the time the outbreak began. Of the 45 patients without burns from whom MARS were isolated, 42 (93%) were surgical patients. MARS were not demonstrated in the air or environment of patients with infected surgical wounds. None of 334 non-burn unit hospital personnel were found to be carriers of MARS. Four phage types (83A, 6/75/85, 29/52/80, and 92) were recovered during the outbreak. A determinant of antibiotic resistance was probably transmitted among strains of S. aureus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 255553     DOI: 10.1093/infdis/139.3.280

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

Review 2.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Antimicrobial resistance takes another step forward.

Authors:  James Maskalyk
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

4.  Evaluation of multiple-locus variable-number tandem-repeat analysis for typing a polyclonal hospital-acquired methicillin-resistant Staphylococcus aureus population in an area where such infections are endemic.

Authors:  Belinda Rivero-Pérez; Eduardo Pérez-Roth; Sebastián Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

Review 5.  MRSA and the environment: implications for comprehensive control measures.

Authors:  N Cimolai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-14       Impact factor: 3.267

6.  Molecular characterization of epidemic ciprofloxacin- and methicillin-resistant Staphylococcus aureus strains colonizing patients in an intensive care unit.

Authors:  E E Udo; I A al-Obaid; L E Jacob; T D Chugh
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  Staying one jump ahead of resistant Staphylococcus aureus.

Authors:  P J Sanderson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

8.  Evaluation of the automicrobic system for detection of resistance of Staphylococcus aureus to methicillin.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

9.  Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals.

Authors:  S Schaefler; D Jones; W Perry; L Ruvinskaya; T Baradet; E Mayr; M E Wilson
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

10.  DNA polymorphisms in methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus.

Authors:  M J Carles-Nurit; B Christophle; S Broche; A Gouby; N Bouziges; M Ramuz
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.